{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=65", "query": { "intervention": "Protein Control", "page": 65 }, "page_size": 10 }, "pagination": { "page": 65, "page_size": 10, "total_count": 3499, "total_pages": 350, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=66&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=64&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-03T06:41:21.638Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06781775", "title": "GDM: Insulin with or Without Metformin?", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Gestational Diabetes" ], "interventions": [ { "name": "Metformin + Insulin", "type": "DRUG" }, { "name": "Insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 130, "start_date": "2024-12-12", "completion_date": "2027-05-01", "has_results": false, "last_update_posted_date": "2025-01-17", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06781775" }, { "nct_id": "NCT03970096", "title": "Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm" ], "interventions": [ { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Thiotepa", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Allogeneic CD34+-enriched and CD45RA-depleted PBSCs", "type": "BIOLOGICAL" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Peripheral Blood Stem Cell", "type": "BIOLOGICAL" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Bone Marrow Aspiration and Biopsy", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "RADIATION", "DRUG", "BIOLOGICAL", "PROCEDURE" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "60 Years", "sex": "ALL", "summary": "1 Year to 60 Years" }, "enrollment_count": 120, "start_date": "2019-11-19", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 3, "location_summary": "Tampa, Florida • Pittsburgh, Pennsylvania • Seattle, Washington", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03970096" }, { "nct_id": "NCT00838903", "title": "Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "albiglutide", "type": "BIOLOGICAL" }, { "name": "sitagliptin", "type": "DRUG" }, { "name": "glimepiride", "type": "DRUG" }, { "name": "metformin", "type": "DRUG" }, { "name": "placebo albiglutide", "type": "BIOLOGICAL" }, { "name": "placebo sitagliptin", "type": "DRUG" }, { "name": "placebo glimepiride", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1049, "start_date": "2009-02", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 317, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Hueytown, Alabama + 254 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00838903" }, { "nct_id": "NCT02413710", "title": "Effects of Soy Protein on Body Composition and General Health in Healthy Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Generally Healthy Kids Consumption Soy Protein Foods as Part of Daily Diet" ], "interventions": [ { "name": "Soy protein containing foods", "type": "OTHER" }, { "name": "Dietary Guidance", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "DuPont Nutrition and Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "8 Years to 11 Years" }, "enrollment_count": 47, "start_date": "2015-02", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2019-10-04", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 1, "location_summary": "Addison, Illinois", "locations": [ { "city": "Addison", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02413710" }, { "nct_id": "NCT01521923", "title": "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Certolizumab Pegol + Methotrexate (MTX)", "type": "BIOLOGICAL" }, { "name": "Placebo + Methotrexate (MTX)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 359, "start_date": "2012-01", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 70, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 63 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Paradise Valley", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01521923" }, { "nct_id": "NCT02889159", "title": "Immunologic Profile of Chronically Photodamaged Skin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Photoaged Skin", "Normal Skin" ], "interventions": [ { "name": "Candida albicans antigen", "type": "BIOLOGICAL" }, { "name": "histamine phosphate", "type": "BIOLOGICAL" }, { "name": "imiquimod 5% cream", "type": "BIOLOGICAL" }, { "name": "Tape Stripping", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2016-06-06", "completion_date": "2023-02-23", "has_results": false, "last_update_posted_date": "2025-02-13", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02889159" }, { "nct_id": "NCT04613024", "title": "Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Weight Loss", "Pain, Postoperative" ], "interventions": [ { "name": "Topamax", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 0, "start_date": "2025-07-01", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2025-04-11", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 0, "location_summary": "Not listed", "locations": [], "official_url": "https://clinicaltrials.gov/study/NCT04613024" }, { "nct_id": "NCT00678080", "title": "Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pregnancy Complications" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Insulin (NPH and Regular)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "52 Years", "sex": "FEMALE", "summary": "18 Years to 52 Years · Female only" }, "enrollment_count": 25, "start_date": "2008-09", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2018-11-28", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 3, "location_summary": "Brownsville, Texas • Houston, Texas", "locations": [ { "city": "Brownsville", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00678080" }, { "nct_id": "NCT02334423", "title": "A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glabellar Frown Lines" ], "interventions": [ { "name": "Botulinum toxin, Type A", "type": "BIOLOGICAL" }, { "name": "0.9% sterile, unpreserved saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Evolus, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 330, "start_date": "2015-01", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2019-03-27", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 1, "location_summary": "Boca Raton, Florida", "locations": [ { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02334423" }, { "nct_id": "NCT03473223", "title": "Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Coronary Syndrome" ], "interventions": [ { "name": "Apolipoprotein A-I [human] (apoA-I)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "CSL Behring", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18226, "start_date": "2018-03-21", "completion_date": "2023-11-17", "has_results": true, "last_update_posted_date": "2025-01-14", "last_synced_at": "2026-11-03T06:41:21.638Z", "location_count": 202, "location_summary": "Alexander City, Alabama • Birmingham, Alabama • Huntsville, Alabama + 175 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03473223" } ] }